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ABSTRACT: In an eﬀort to evaluate whether a recently
reported putative metallo-β-lactamase (MβL) contains a novel
MβL active site, SPS-1 from Sediminispirochaeta smaragdinae
was overexpressed, puriﬁed, and characterized using spectro-
scopic and crystallographic studies. Metal analyses demonstrate
that recombinant SPS-1 binds nearly 2 equiv of Zn(II), and
steady-state kinetic studies show that the enzyme hydrolyzes
carbapenems and certain cephalosporins but not β-lactam
substrates with bulky substituents at the 6/7 position.
Spectroscopic studies of Co(II)-substituted SPS-1 suggest a
novel metal center in SPS-1, with a reduced level of spin
coupling between the metal ions and a novel Zn1 metal binding
site. This site was conﬁrmed with a crystal structure of the enzyme. The structure shows a Zn2 site that is similar to that in
NDM-1 and other subclass B1 MβLs; however, the Zn1 metal ion is coordinated by two histidine residues and a water molecule,
which is held in position by a hydrogen bond network. The Zn1 metal is displaced nearly 1 Å from the position reported in
other MβLs. The structure also shows extended helices above the active site, which create a binding pocket that precludes the
binding of substrates with large, bulky substituents at the 6/7 position of β-lactam antibiotics. This study reveals a novel metal
binding site in MβLs and suggests that the targeting of metal binding sites in MβLs with inhibitors is now more challenging with
the identiﬁcation of this new MβL.
β-Lactam antibiotics, such as penicillins, cephalosporins, and
carbapenems, have long served as treatments for bacterial
infections by inactivation of bacterial transpeptidases. These
compounds constitute the largest class of clinically available
antibiotics. In response to wide use, and overuse, of β-lactam-
containing drugs, bacteria have evolved to produce β-
lactamases that hydrolyze the β-lactam bond and render the
antibiotics inactive.
Of the four classes of β-lactamases (A−D), only class B
enzymes require one or two Zn(II) ions, rather than an active
site serine, for catalysis and are termed metallo-β-lactamases
(MβLs).1−3 MβLs adopt an αββα fold, and among the three
subclasses (B1−B3), B1 and B3 MβLs generally contain a
dinuclear Zn(II) active site, while B2 MβLs are active with
mononuclear Zn(II) sites. The B1 MβLs coordinate one
Zn(II) (in the Zn1 site) with three histidine residues, while the
Zn(II) in the Zn2 site is bound to one cysteine, one aspartate,
one histidine, and a terminally bound solvent molecule. The
Zn(II) ions are bridged by a solvent molecule, resulting in a
Zn−Zn distance of 3.3−3.9 Å.2,4 The B3 MβLs possess the
same Zn1 site as the B1 MβLs; however, in the Zn2 site, the
cysteine ligand is replaced with an additional His residue.
Subclass B1 contains the largest number of clinically relevant
MβLs, including VIMs (Verona integrin-encoded MβL), IMPs
(imipenemase), and NDMs (New Delhi MβL). Most recent
studies have focused on MβLs found in pathogenic strains;
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however, the risk of transfer of antibiotic resistance
determinants from a nonpathogenic strain to a more clinically
relevant organism necessitates the need to study MβLs not yet
found in known human pathogens.5
Recently, with the use of a Markov model and a
bioinformatic study, Berglund et al. identiﬁed 279 unique,
potential subclass B1 MβL genes, and 76 of the corresponding
gene products were novel and able to hydrolyze imipenem.6
One gene, SPS-1, was found in the bacterium Sediminispir-
ochae ta smaragdinae (NCBI re ference sequence
WP_013255389.1). S. smaragdinae strain SEBR 4228T was
discovered in a water sample near a Congo oﬀshore oilﬁeld.7
SEBR 4228T is a Gram-negative, chemoorganotrophic, and
anaerobic bacterium that adopts a spiral, corkscrew-like
structure. This organism is halophilic and able to grow in
high-salt environments. SPS-1 was predicted to be a MβL;
however, SPS-1 lacked the typical H-X-H-X-D motif found in
all MβLs except the B2 MβLs. In SPS-1, the ﬁrst consensus
histidine residue was substituted with a glycine.6 In an eﬀort to
determine if SPS-1 is indeed a MβL and how the histidine to
glycine substitution aﬀected the consensus Zn1 site, we cloned,
overexpressed, and puriﬁed the enzyme and characterized the
recombinant protein via kinetic, spectroscopic, and crystallo-
graphic studies.
■ MATERIALS AND METHODS
Phylogenetic Analysis of SPS-1. The protein sequences
of selective class B β-lactamases (MβLs), as well as SPS-1, were
downloaded from the NCBI GenBank and analyzed using
Phylogeny.fr (http://www.phylogeny.fr/).8,9
Cloning, Overexpression, and Puriﬁcation of SPS-1. A
codon-optimized SPS-1 sequence (residues 32−276) fused
with an N-terminal tobacco etch virus (TEV) cleavage site was
synthesized by Genscript Biotech Corp. The synthesized
fragment was subcloned into pET28a between the NdeI and
XhoI restriction sites. The resulting overexpression plasmid,
pET28a-SPS-1, was transformed into Escherichia coli EXPRESS
BL21(DE3) Chemically Competent cells (Lucigen). A single
colony was transferred into 50 mL of lysogeny broth (LB)
containing 50 μg/mL kanamycin, and the culture was shaken
overnight at 37 °C. The overnight culture (10 mL) was used to
inoculate four 1 L LB cultures containing 50 μg/mL
kanamycin. The resulting culture was grown at 37 °C with a
shaking speed of 220 rpm until an OD600 of 0.6 was reached.
Protein production was induced by addition of isopropyl β-D-
1-thiogalactopyranoside (IPTG) to a ﬁnal concentration of
500 μM. At the time of induction, cultures were supplemented
with Zn(II) with addition of ZnCl2 to a concentration of 100
μM. Cultures were shaken overnight at 18 °C and then
harvested by centrifugation for 10 min at 8000g. Cell pellets
were resuspended in 50 mL of 50 mM HEPES (pH 7.5)
containing 500 mM NaCl. Cells were lysed by passing the
mixture two times through a French press at a pressure
between 15000 and 20000 psi. The insoluble components were
removed by centrifugation for 1 h at 32000g. The supernatant
was loaded onto a HisTrap HP (5 mL, GE) column and
washed with 10 volumes of wash buﬀer containing 50 mM
HEPES (pH 7.5), 500 mM NaCl, and 50 mM imidazole.
Bound proteins were eluted using elution buﬀer (wash buﬀer
with 500 mM imidazole). TEV protease was added at a 1:100
(w/w) ratio to SPS-1. The eluted proteins were dialyzed
against 1 L of 50 mM HEPES (pH 7.5) containing 500 mM
NaCl. After overnight dialysis, the truncated SPS-1 protein was
repuriﬁed by being passed through a HisTrap column, which
removed the His6-TEV and His6 tag.
Puriﬁed recombinant SPS-1 (before and after TEV
digestion) was analyzed by sodium dodecyl sulfate−poly-
acrylamide gel electrophoresis (SDS−PAGE) using a Fisher
EZ-Gel solution (12.5%), a Mini-PROTEAN System (Bio-Rad
Laboratories), and Coomassie Blue stain. Protein concen-
trations were determined by ultraviolet−visible (UV−vis)
absorbance at 280 nm using an ε280 of 35535 M
−1 cm−1 for the
SPS-1 protein containing the His6 tag and an ε280 of 34045
M−1 cm−1 for the SPS-1 protein without the His6 tag. These
extinction coeﬃcients were calculated using ExPASY ProtPar-
am.10
Matrix-Assisted Laser Desorption Ionization Time-of-
Flight (MALDI-TOF) Mass Spectrometry. After dialysis
against 10 mM ammonium acetate (pH 7.5), 30 μM tag-free
SPS-1 was mixed with a sinapinic acid matrix at a ratio of 1:1.
The resulting sample was analyzed using a Bruker AutoFlex
MALDI-TOF mass spectrometer.11
Fluorescence Spectroscopy. Fluorescence emission
spectra of SPS-1 were recorded on a PerkinElmer lumines-
cence spectrometer (model LS-55) using 2 μM SPS-1 in 50
mM HEPES (pH 7.5). Spectra were acquired using an
excitation wavelength of 280 nm and an emission spectrum
window from 300 to 500 nm.
Metal Analyses. The zinc contents of puriﬁed SPS-1
samples were determined using a PerkinElmer Optima 7300V
inductively coupled plasma spectrometer with optical emission
spectroscopy (ICP-OES) detection. Protein samples, used
without modiﬁcation after puriﬁcation, were diluted to 5 μM
with 10 mM ammonium acetate (pH 7.5). Calibration curves
were generated using serial dilutions of FisherBrand Zn metal
standard ranging from 0 to 16 μM, and the emission line at
202.548 nm was chosen for zinc.
Steady-State Kinetics. Steady-state kinetic studies were
performed using a Synergy HT Multi-Mode Microplate Reader
(Biotek) at 37 °C in 50 mM HEPES (pH 7.5) containing 150
mM NaCl and 10 μM ZnCl2. The following changes in molar
absorptivity (Δε, M−1 cm−1) were used to quantitate products:
chromacef, Δε442 = 18600; cephalothin, Δε265 = −8790;
imipenem, Δε300 = −9000; meropenem, Δε293 = −7600;
ampicillin, Δε235 = −809; penicillin G, Δε235 = −936;
cefuroxime, Δε260 = −5860; and cephalexin, Δε260 =
−7750.12 Initial rates (within 18 s) versus substrate
concentrations were ﬁtted to the Michaelis−Menten equation
to determine the steady-kinetic constants Km and kcat using
Prism 7 (Graphpad Software).
Isothermal Titration Calorimetry. Isothermal titration
calorimetry (ITC) experiments were performed using a Nano
ITC System (TA Instruments-Waters LLC) with a 500 μL cell.
All experiments were performed at 25 °C. SPS-1 and NDM-1
were prepared by diluting the stock solutions with 20 mM
HEPES (pH 7.5) containing 150 mM NaCl. L-Captopril
(Acros Organics) was dissolved in the same buﬀer. The ITC
cell was ﬁlled with 50 μM NDM-1 or SPS-1 (300 μL), and the
enzyme solutions were titrated with 250 μM captopril. The
injection volume was 50 μL, and the time between two
injections was 210 s. Kd values were determined by using
NanoAnalyze (TA Instruments-Waters LLC).
Preparation of Metal-Free Proteins. Metal-free forms of
SPS-1 and NDM-1 were prepared through metal chelation.
Each puriﬁed protein (diluted to 50 μM in 20 mL) was placed
in a 10 kDa molecular weight cutoﬀ dialysis bag. These
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samples were dialyzed versus dialysis buﬀers for 4 h at 4 °C
before changing to the subsequent dialysis buﬀer to include a
series of ﬁve dialysis steps: ﬁrst, two changes of 50 mM HEPES
(pH 6.8) containing 150 mM NaCl with 2 mM EDTA and,
then, three changes of 50 mM HEPES (pH 6.8) containing
150 mM NaCl. The resulting metal-free enzymes were
analyzed by using SDS−PAGE and UV−vis and concentrated
by using an Amicon Ultra 15 mL centrifugal ﬁlter (10K).
UV−vis Spectroscopy. Metal-free SPS-1 and NDM-1
were diluted to 300 μM with 50 mM HEPES (pH 6.8)
containing 150 mM NaCl and 1 mM tris(2-carboxyethyl)-
phosphine (TCEP). One or two molar equivalents of CoCl2
was added to the protein samples from a 50 mM stock
solution. The resulting mono-Co(II)-substituted or di-Co(II)-
substituted protein samples were placed in 500 μL quartz
cuvettes, and UV−vis spectra were recorded on a PerkinElmer
Lambda 750 UV/vis/NIR spectrometer that measured the
absorbance between 300 and 700 nm at 25 °C. The blank
spectrum of 300 μM apo-SPS-1 or apo-NDM-1 in 50 mM
HEPES (pH 6.8) containing 150 mM NaCl and 1 mM TCEP
was used to generate diﬀerence spectra. All data were
normalized to the absorbance at 700 nm.
NMR Spectroscopy. Metal-free SPS-1 was concentrated to
∼0.5 mM with an AmiconUltra-15 centrifugal unit and an
Ultracel-10 membrane. To the concentrated protein was added
2 equiv of CoCl2 in the buﬀer containing 50 mM HEPES (pH
6.8), 150 mM NaCl, and 10% (v/v) D2O. Spectra were
recorded at 292 K on a Bruker ASX300 (BBI probe) NMR
spectrometer operating at a frequency of 300.16 MHz. Spectra
were collected using a frequency switching method, applying a
long low-power (270 ms) pulse centered at the water
frequency, followed by a high-power 3 μs pulse centered at
either 200 or 90 ppm to ensure all resonances were detected.13
This method allowed for suppression of the water signal with
enhancement of severely hyperﬁne-shifted resonances. Spectra
consisted of 120000 transients of 16K data points over a 333
ppm spectral window (τaq ∼ 51 ms). Signal averaging took ∼12
h per spectrum.
EPR Spectroscopy. EPR samples containing SPS-1 or
NDM-1 included approximately 10% (v/v) glycerol as a
glassing agent. Samples were loaded into EPR tubes and
degassed by repeated evacuation/purging with N2 prior to data
collection. Spectra were recorded on a Bruker EMX EPR
spectrometer, equipped with an ER4116-DM dual-mode
resonator (9.37 GHz, parallel; 9.62 GHz, perpendicular).
The data in EPR ﬁgures were scaled so that the X-axes
matched (perpendicular mode ﬁeld values were scaled by 9.37/
9.62). The temperature was controlled using an Oxford
ESR900 cryostat and temperature controller (4.5 K). Other
spectral conditions included a microwave power of 0.2 mW, a
ﬁeld modulation of 10 G (100 kHz), a receiver gain of 104, and
a time constant/conversion time of 41 ms.
Crystallization, Diﬀraction Data Collection, and
Structural Reﬁnement. SPS-1 was crystallized using 96-
well sitting drop vapor diﬀusion screens prepared using a
Phoenix crystallization robot (Art Robbins). The sitting drops
contained 400 nL of 1.45 mM SPS-1 and 400 nL of the
crystallization condition. Six crystallization screens were used:
MCSG 1−4 by Microlytic and JCSG and PACT++ by
JBScreen. Diﬀraction quality crystals formed within 2 weeks
under a condition consisting of 0.2 M magnesium chloride, 0.1
M sodium cacodylate (pH 6.5), and 50% (v/v) PEG 200. For
Figure 1. Phylogenetic tree of class B metallo-β-lactamase sequences. The protein sequences of SPS-1 and other selective metallo-β-lactamase were
downloaded and analyzed by Phylogeny.fr. The sequence include SPS-1 (WP_013255389.1), BcII (M11189), CcrA (M63556), IMP-1 (S71932),
VIM-2 (AF191564), BlaB (AF189298), SPM-1 (AY341249), NDM-1 (JN420336), GIM-1 (AJ620678), SIM-1 (AY887066), DIM-1 (GU323019),
TMB-1 (FR771847), Bla2 (CP001598), KHM-1 (AB364006), CphA (X57102), Sfh-1 (AF197943), ImiS (Y01415), L1 (AB294542), FEZ-1
(Y17896), BJP-1 (NP772870), AIM-1 (AM998375), THIN-B (CAC33832), GOB-1 (ABO21417), CAU-1 (CAC87665), CAR-1 (Q6D395),
SMB-1 (AB636283), POM-1 (ADC79555), and CRB11 (ACS83724). The line segment with the number 0.6 shows the length of the branch that
represents an amount of genetic change of 0.6.
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crystal harvesting, MiTeGen MicroLoops were used to harvest
crystals that had been cryoprotected with LV CryoOil and then
immediately frozen in liquid nitrogen. Crystals were sent to the
Advanced Light Source (ALS) at Lawrence Berkeley National
Laboratory where X-ray diﬀraction data were collected. Data
were integrated and scaled using XDS14 and SCALA.15 Data
resolution cutoﬀs were determined using a combination of
criteria, including completeness and CC1/2. Molecular
replacement was conducted with PHASER16 using a
polyalanine search model produced from the structure of
SPM-1 [Protein Data Bank (PDB) entry 4BP0].17 The SPS-1
amino acid sequence was then docked to the molecular
replacement solution. Iterative model building and reﬁnement
were conducted using COOT18 and PHENIX19 using isotropic
individual B factors and TLS reﬁnement.20 Stereochemical and
geometric quality analyses were performed with MolProbity
Table 1. Steady-State Kinetic Parameters for Diﬀerent β-Lactams with SPS-1, NDM-1, and SPM-1
SPS-1 SPM-112 NDM-127,28
substratea Km (μM) kcat (s
−1) kcat/Km (s
−1 μM−1) Km (μM) kcat (s
−1) kcat/Km (s
−1 μM−1) Km (μM) kcat (s
−1) kcat/Km (s
−1 μM−1)
chromacef 120 ± 9 2.6 ± 0.1 0.021 not available 5.1 ± 0.9 4.2 0.8
ampicillin not observed 72 ± 3 120 ± 2 1.6 22 15 0.66
penicillin G not observed not available 16 11 0.68
imipenem 290 ± 50 470 ± 60 1.63 37 ± 4 33 ± 2 1 94 20 0.21
meropenem 170 ± 30 520 ± 50 3 280 ± 30 63 ± 3 0.22 49 12 0.25
cephalothin 110 ± 20 3.1 ± 0.1 0.027 4 ± 1 43 ± 2 11.7 10 4 0.4
cefuroxime not observed 4 ± 1 37 ± 3 8.8 8 5 0.61
cephalexin not observed not available not available
aThe buﬀer consisted of 50 mM HEPES (pH 7.5) containing 150 mM NaCl and 10 μM ZnCl2.
Figure 2. ITC results of L-captopril titrations with NDM-1 and SPS-1. The top panel shows the titration thermograms, and the bottom panel shows
the data integration with ﬁtted curves. Data for the NDM-1 protein are colored red, and data for SPS-1 are colored blue.
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version 4.4.21 The ﬁnal model and structure factors were
deposited in the Protein Data Bank as entry 6CQS.
■ RESULTS
Phylogenetic Analysis of SPS-1. MβLs can be grouped
into three subclasses phylogenetically.1 Subclass B1 MβLs
contain a Zn1 binding site with three histidine residues
(His116, His118, and His196) and a Zn2 site with three other
residues (Asp120, Cys221, and His263).1−3 Subclass B2 MβLs
contain a Zn1 site with one altered residue (Asn116, His118, or
His196) and a Zn2 site identical to that of the subclass B1
MβLs; the altered Zn1 site results in B2 MβLs exhibiting
activity as mononuclear Zn(II) enzymes.22,23 The subclass B3
MβLs have a varied Zn1 binding site (His/Gln116, His118,
and His196) and a distinctive Zn2 binding site, which does not
contain a cysteine residue (Asp120, His121, and His263). To
determine the phylogenetic position of SPS-1 in the
classiﬁcation of MβLs, phylogenetic analysis was conducted
using Phylogeny.8 The analyses showed that enzymes in
subclasses B1 and B2 descended from a common ancestor and
that SPS-1 was grouped in the B1 class and is highly similar to
the MβL SPM-1 (Figure 1).12 Subgroup B3 MβLs are
divergent from subgroups B1 and B2.
Overexpression, Puriﬁcation, and Characterization of
ZnZn-SPS-1. A region of the gene for SPS-1 corresponding to
residues 32−276 was synthesized to aid in cloning SPS-1 into a
pET28A overexpression vector. The DNA sequence corre-
sponding to the ﬁrst 31 amino acids was not included as these
residues were predicted by Phobius24 to comprise a signal
peptide. Overexpressed SPS-1 was puriﬁed with a single-step
HisTrap column. TEV protease was used to remove the His6
tag, and a second HisTrap column was used to separate SPS-1
from the cleaved tag and TEV protease. The purity of the
protein was shown to be >95% by SDS−PAGE. The predicted
molecular weight for tag-free SPS-1 is 27466.11 Da, as
determined by the ExPASy-Compute pI/Mw tool.10 The
MALDI-TOF mass spectrum of tag-free SPS-1 showed a single
peak at m/z 27469 ± 267 (Figure S1), which demonstrated
that the protein was puriﬁed as a single polypeptide. The yield
for tag-free SPS-1 was >20 mg of protein/L of LB medium.
The tertiary structure of recombinant SPS-1 was evaluated
using ﬂuorescence spectroscopy. The resulting spectrum
showed a single peak at 345 nm (excitation at 280 nm),
suggesting that the majority of the protein consisted of one
folded conformation (data not shown).25 ICP-AES revealed
that SPS-1 binds 1.9 ± 0.1 equiv of Zn(II), similar to the metal
content of NDM-1 and other well-characterized dinuclear
Zn(II)-containing MβLs.4,26
Steady-State Kinetics. Steady-state kinetic studies were
conducted at 37 °C using chromacef, ampicillin, penicillin G,
imipenem, meropenem, cephalothin, cefuroxime, and cepha-
lexin as substrates. The resulting kinetic data are listed in Table
1. When using chromacef and cephalothin as the substrate,
SPS-1 exhibited Km values of 120 ± 9 and 110 ± 20 μM and
kcat values of 2.6 ± 0.1 and 3.1 ± 0.1 s
−1, respectively. When
using imipenem and meropenem as substrates, SPS-1 exhibited
Km values of 290 ± 50 and 170 ± 30 μM and kcat values of 470
± 60 and 520 ± 50 s−1, respectively. When ampicillin,
penicillin G, cefuroxime, and cephalexin were used as
substrates, no activity was observed. Compared to those of
NDM-1 and SPM-1, the Km values with diﬀerent substrates
exhibited by SPS-1 are much larger, resulting in lower catalytic
eﬃciencies (Table 1). In contrast to most other MβLs,1,2 SPS-
1 exhibits substrate speciﬁcities for carbapenems and certain
cephalosporins.
Isothermal Titration Calorimetry (ITC). ITC was used to
determine if SPS-1 binds to L-captopril, which has been
reported to be a competitive inhibitor of several MβLs.29
Previous studies have shown that the S1 atom in L-captopril
inserts directly between the metal ions in NDM-1,29 displacing
the bridging water/hydroxide. The crystal structure of the
NDM-1/captopril complex showed that L-captopril has two
binding faces: a hydrophobic face that interacts with Val73 and
Met67 of the L3 loop and a hydrophilic face that hydrogen
bonds to Asn220 on the L10 loop.29 Under our experimental
conditions, L-captopril binds to NDM-1 with a Kd value of 1.95
μM (Figure 2), while there is no binding between SPS-1 and L-
captopril at L-captopril concentrations of ≤50 μM. This result
suggests a diﬀerent active site conﬁguration in SPS-1 compared
to that in NDM-1.
UV−Vis Spectroscopy. To obtain information about the
metal binding sites in SPS-1, UV−vis spectra of Co(II)-
substituted SPS-1 were recorded, and Co(II)-substituted
NDM-1 was used as a control.27 Metal-free SPS-1 and
NDM-1 were prepared as described in Materials and Methods.
TCEP was added to metal-free SPS-1, prior to adding Co(II),
to prevent Co(II) oxidation.27 Glycerol (10%) was added to
the metal-free SPS-1 before Co(II) addition to prevent protein
precipitation.30 As previously reported,26,27 Co(II)-substituted
NDM-1 exhibited an intense peak at 330 nm, which was
previously attributed to a Cys-S to Co(II) ligand-to-metal
charge transfer transition.31−34 The other peaks at 330, 510,
549, 615, and 640 nm (Figure 3) were assigned to ligand ﬁeld
transitions of high-spin Co(II) exhibiting a Jahn−Teller
distortion.31,35 The extinction coeﬃcients of these ligand
ﬁeld transitions are consistent with one Co(II) having a
coordination number of 4 and the other having a coordination
number of 5.26 Conversely, the spectra of Co(II)-substituted
SPS-1 revealed a sharp absorption at 346 nm (Figure 3),
suggesting a similar Zn2 site in SPS-1 and NDM-1. However,
in the spectra of Co(II)-substituted SPS-1, the ligand ﬁeld
transitions between 500 and 650 nm are broader and lack
distinct features. Importantly, the extinction coeﬃcient of this
peak is 56 M−1 cm−1 [or ∼28 M−1 cm−1 per Co(II)],
Figure 3. UV−vis spectra of apo-NDM and apo-SPS-1 treated with
CoCl2. The apoprotein (300 μM) with 50 mM HEPES (pH 6.8)
containing 150 mM NaCl was used as a blank in this experiment.
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suggesting that both Co(II) ions are six-coordinate.26 A similar
spectrum was previously reported for Co(II)-substituted L1.36
NMR Spectroscopy of Co(II)-Substituted SPS-1. To
further probe the metal binding sites in SPS-1, 1H NMR
spectra of Co(II)-substituted SPS-1 were recorded (Figure 4).
As with the UV−vis spectra presented above, Co(II)-
substituted NDM-1 was used as a control. Previously for
Co(II)-substituted NDM-1, we showed that resonances at 64,
72, and 79 ppm are due to solvent-exchangeable protons on
His120, His122, and His189 in the Zn1 site, respectively, and
resonances at 48, 107, and 165 ppm correspond to protons on
Asp124, His250, and Cys208 in the Zn2 site, respectively.
27
The spectrum of Co(II)-substituted SPS-1 revealed signiﬁcant
changes to the active site compared to NDM-1. Resonances at
249 and 217 ppm may be the geminal pair arising from the β-
CH2 cysteine ligand coordinating the Zn2 site, although
another weak signal was seen at 164 ppm that aligns well with
the β-CH2 cysteine protons of Co(II)-substituted NDM-1.
The SPS-1 data, therefore, suggest two distinct conformations
for Cys208 or that only two of the three resonances arise from
Cys208.37 Three relatively strong resonances were observed at
96, 74, and 54 ppm and can be assigned to the three Co(II)-
bound histidine ligands (two from the Zn1 site and one from
the Zn2 site). A spectrum of Co(II)-substituted SPS-1
containing 90% (v/v) D2O was recorded to verify that these
three resonances were solvent-exchangeable (Figure S2). The
absence of these three resonances in the D2O spectrum further
supports the hypothesis that they arise from the three Co(II)-
coordinated histidine residues. Other resonances at 31 and 23
ppm do not appear to be solvent-exchangeable and may be due
to either one or both α-CH2 aspartate protons. Of the
remaining weak signals [66, 62, 48, and −27 ppm (see Figure
S2)], most are likely contributions from second-sphere
interactions with the metal sites. In total, these results align
well with the two predicted histidine ligands at the Zn1 site and
one histidine at the Zn2 site and show distinct diﬀerences
between the active site structures of SPS-1 and NDM-1.
EPR Spectroscopy of Metal-Substituted SPS-1. Con-
tinuous wave EPR spectra of CoCo-SPS-1 and CoCo-NDM-1,
obtained in both parallel and perpendicular modes, are shown
in Figure 5. Both perpendicular mode spectra are typical of
high-spin Co(II)-substituted metalloproteins.38 Aside from
modulation of the line shape, signiﬁcant changes to the
electronic environment of the Co(II) ions were not observed
in these data. The sharp peak between 1600 and 1700 G in the
diCo(II)-substituted NDM-1 spectrum was caused by a small
fraction of Fe(III) contamination; a similar peak has been
observed in previous EPR spectra of Co(II)-substituted NDM-
1.27 Co(II)-substituted NDM-1 also showed tightly coupled,
active site Co(II) ions in the parallel mode spectra (a deep
negative feature near 800 G).38 However, no such feature was
observed in the spectrum of Co(II)-substituted SPS-1,
indicating weaker coupling of active site Co(II) ions in SPS-1.
Crystal Structure of SPS-1. The structure of SPS-1 was
determined to 1.70 Å resolution featuring an asymmetric unit
containing a single protomer. Details of the crystallographic
reﬁnement are listed in Table 2. Two Zn(II) ions are bound in
the active site, and a third zinc ion is coordinated by the side
chains of the His110 and Asp106 residues of the single
protomer within the asymmetric unit and the His110 and
Figure 4. 1H NMR (300 MHz) spectra of Co(II)-substituted NDM-1
(1 mM) and SPS-1 (0.5 mM).
Figure 5. EPR spectra of Co(II)-substituted MβLs. Perpendicular and
parallel mode, X-band EPR spectra of Co(II)-substituted NDM-1 and
SPS-1. The enzyme concentration in both samples was 0.9 mM.
Table 2. Crystallographic Data for SPS-1
Data Collection
beamline ALS 4.2.2
wavelength (Å) 1.0000
space group P43212
a, b, c (Å) 73.60, 73.60, 108.78
α, β, γ (deg) 90, 90, 90
resolution rangea (Å) 34.86−1.70 (1.76−1.70)
no. of reﬂectionsa 157508 (6969)
no. of unique reﬂectionsa 33588 (3290)
completenessa (%) 99.95 (100.00)
Wilson B factor (Å2) 19.5
CC1/2
a 99.5 (70.5)
Reﬁnement
no. of reﬂectionsa 33588 (3290)
PDB entry 6CQS
Rwork/Rfree 0.176/0.194
no. of atoms (protein/water/ligands) 1939/151/3
average B factor (Å2) (protein/water/
ligands)
24.9/32.9/24.5
Model Quality
rmsd for bond lengths (Å) 0.010
rmsd for bond angles (Å) 1.073
Ramachandran favoredb (%) 98.75
Ramachandran outliersb (%) 0.00
poor rotamersb (%) 0.00
Clash scoreb 0.78
Clash percentileb 99th percentile (N = 819;
1.70 ± 0.25 Å)
MolProbity scoreb 0.75
MolProbity score percentileb 100th percentile (N = 9248;
1.70 ± 0.25 Å)
aValues in parentheses are for the highest-resolution shell. bValues as
determined by MolProbity version 4.4 (http://molprobity.biochem.
duke.edu/).
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Asp106 side chains of the −X, −Y, −Z + 1/2 symmetry mate.
This third Zn(II) ion assists in the formation of crystal
contacts and is unlikely to be physiologically relevant. The
SPS-1 structure (Figure 6a,b), generated in part by Pro-
origami,39 exhibits the canonical αββα metallo-β-lactamase
fold with two separate β-sheets and interstrand loops
facilitating coordination of the active site zinc ions. SPS-1
overlays with a 0.92 Å root-mean-square deviation (rmsd)
from SPM-1 for all backbone heavy atoms, indicating similar
structures for both enzymes. The overlay of SPS-1 and NDM-1
is slightly poorer, exhibiting a 1.10 Å rmsd for all backbone
heavy atoms. Despite a slightly worse rmsd, SPS-1 exhibits a
high degree of structural similarity to both SPM-1 and NDM-1.
Similar to SPM-1, SPS-1 features a pair of extended α-helices
(Figure 6a,c), helices α3 and α4, located above the active site.
The orientation of SPS-1 helix α3 is diﬀerent in SPS-1 and
SPM-1, which oﬀers a potential avenue to the diﬀerential
substrate selectivity observed for SPS-1 compared to that of
SPM-1. In comparison, these helices are not found in NDM-1
(Figure 6d), and NDM-1 does not exhibit the substrate
speciﬁcity observed with SPS-1. In contrast, the β-hairpin loop
found in NDM-1 is signiﬁcantly truncated in both SPS-1 and
SPM-1. However, while the absence of corresponding helices
α3 and α4 in NDM-1 expands the active site, the shortened β-
hairpin loop of SPS-1 provides little in the way of expansion of
the active site that could be utilized to accommodate substrates
with bulky substituents as found in ampicillin, cephalexin, and
cefuroxime.
SPS-1 Active Site. The active sites of SPS-1, SPM-1, and
NDM-1 (Figure 7a) all feature two Zn(II) ions coordinated by
the side chains of histidine, aspartate, or cysteine residues. The
Zn2 sites of SPS-1 (Figure 7b), SPM-1 (Figure 7c), and NDM-
1 (Figure 7d) are nearly identical, each exhibiting coordination
by active site histidine (SPS-1 His245, SPM-1 His258, and
NDM-1 His250), aspartate (SPS-1 Asp100, SPM-1 Asp112,
and NDM-1 Asp124), and cysteine (SPS-1 Cys207, SPM-1
Cys216, and NDM-1 Cys208) residues. While each protein
features at least two histidine residues serving to coordinate
Zn1 (SPS-1 His98 and His188, SPM-1 His110 and His197,
and NDM-1 His122 and His189), SPS-1 is missing the third
coordinating histidine (SPM-1 His108 and NDM-1 His120).
In the place of His108/His120, SPS-1 harbors a glycine residue
(Gly96). The substitution of a glycine at this position opens up
substantial space in the SPS-1 active site below Zn1. As a result,
SPS-1 features two water molecules that form a hydrogen bond
network with SPS-1 active site residues. These two water
molecules are featured clearly in the 2Fo − Fc map (Figure
8a,b) and in an omit map generated by Polder (Figure 8c,d).40
While additional density in the omit map near Zn1 is likely the
result of truncation artifacts in the Fourier series near the zinc
ions or anisotropic motion that is not readily ﬁt by isotropic B
factors, the omit map density clearly ﬁts the proximal and distal
water molecules.41 The water molecule proximal to Gly96 is
held in place by a hydrogen bond to the backbone amide
proton of Tyr97 and the active site water molecule proximal to
Gly96. This proximal water molecule is further anchored by a
Figure 6. Overall structure of S. smaragdinae SPS-1. (a) The structure
of SPS-1 features the canonical αββα metallo-β-lactamase fold with
two zinc ions coordinated at the active site. Residues that coordinate
zinc ions at the active site are shown as sticks, and zinc ions are shown
as spheres (gray). (b) A cartoon schematic, generated in part by Pro-
origami, indicates the organization of the protein and the contribution
of loop residues to coordination of Zn1 and Zn2. (c) An overlay of
SPS-1 (green) with SPM-1 (blue, PDB entry 4BP0) highlights the
similar overall structure. (d) An overlay of SPS-1 (green) with NDM-
1 (pink, PDB entry 4EXS) highlights a shortened SPS-1 β-hairpin
loop between β-strands β3 and β4 and extended α-helices α3 and α4
above the active site for SPS-1 compared to NDM-1. For panels c and
d, residues that coordinate zinc ions at the active site are shown as
sticks and zinc ions are shown as spheres (SPS-1, gray; SPM-1, navy
blue; NDM-1, purple).
Figure 7. Organization of the S. smaragdinae SPS-1 active site. (a)
The active sites of SPS-1 (green), SPM-1 (pink, PDB entry 4BP0),
and NDM-1 (blue, PDB entry 4EXS) are shown as an overlay. (b)
The active site of SPS-1 identiﬁes a water molecule that coordinates
to Zn1 in place of a histidine from the canonical HxHxD motif and a
second water molecule that completes the hydrogen bond network
(black dashed lines) with Gly96 and Asn192. The active sites of (c)
SPM-1 and (d) NDM-1 feature the full complement of expected
ligands. Throughout, key residues are shown as sticks and identiﬁed
by residue name and number and zinc ions are shown as spheres
(SPS-1, gray; SPM-1, navy blue; NDM-1, purple).
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hydrogen bond to the side chain NH2 of Asn192 and
coordinates Zn1. The presence of the distal and proximal
water molecules is made possible by a single amino acid
substitution outside the primary coordination sphere. SPS-1
Thr187 is a bulky residue in comparison to SPM-1 Ala196 and
NDM-1 Gly98, which results in a change in the preferred
rotamer for Asn192, thereby setting the stage for the water-
mediated hydrogen bond network that situates the Gly96 distal
water in position to coordinate Zn1.
The coordinating residues and the ions in the Zn2 sites
harbor similar positions as the average distance between the
Zn2 site zinc ions across the SPS-1, SPM-1, and NDM-1
structures is 0.57 ± 0.14 Å. In comparison, an altered Zn1
coordination sphere has a signiﬁcant eﬀect on the location of
Zn1 within the active site. The Zn1 site for SPS-1 diverges from
those observed for SPM-1, NDM-1, and all other structurally
characterized metallo-β-lactamases.1−3 While the position of
Zn2 is relatively invariant, the position of SPS-1 Zn1 diﬀers
from those of SPM-1 Zn1 and NDM-1 Zn1 by 1.11 ± 0.01 Å
(Figure S3). In comparison, the Zn1 sites of SPM-1 and NDM-
1 diﬀer by only 0.43 Å. The approximately 1 Å shift of SPS-1
Zn1 upward, away from Gly96, appears to be a direct
consequence of the altered primary coordination sphere.
Thus, diﬀerences in the primary (Gly96) and secondary
(Thr187) coordination spheres elicit diﬀerences in the location
of SPS-1 Zn1 in comparison to SPM-1 and NDM-1.
■ DISCUSSION
A recent bioinformatics study revealed 279 unique, putative
MβL genes, and initial biochemical and microbiological studies
conﬁrmed that 76 of the resulting proteins could be MβLs.6
One member of this group, SPS-1 from S. smaragdinae, was
particularly interesting because it appeared to lack the
consensus HXHXD motif found in all MβLs, except those
belonging to the B2 subgroup.1−3 We were intrigued by the
possibility of a novel metal binding site never before observed
in the MβLs. Therefore, we endeavored to biochemically and
structurally characterize SPS-1.
SPS-1 contains 276 amino acids and shares the highest
degree of sequence similarity with SPM-1 from Pseudomonas
aeruginosa (Figure 1).12 The overlay of the SPS-1 and SPM-1
structures reveals a 0.92 Å rmsd, indicating broad structural
similarity (Figure 6a,c). In addition, both SPS-1 and SPM-1
have a pair of helices located above the active site, and a
similarly positioned helix is not found in NDM-1 (Figure
6a,c,d). Even though SPS-1 was sorted into the B1
phylogenetic class, it may also share some similarity with
subgroup B2 MβLs, which contain one zinc in the active site
(the consensus Zn2 site) and exhibit a narrow substrate
spectrum.2 While NDM-1, VIM-2, and IMP-1 from the B1
subclass can hydrolyze penems, cephems, and carbapenems,
CphA, Sfh-1, and ImiS from the B2 subclass can hydrolyze
only carbapenems.42 Surprisingly, SPS-1 exhibited signiﬁcant
activity against carbapenems, no activity against a penam, and
weak and/or selective activity against cephem (Table 1). The
most likely explanation for the absence of activity against
ampicillin, penicillin G, cefuroxime, and cephalexin is steric
clashes with Trp48 and Thr146 located on the extended
helices α3 and α4 in SPS-1 (Figures 6, 7, and 9). Overlaying
SPS-1 onto structures of NDM-1 in complex with ampicillin,43
cephalexin,44 and cefuroxime44 demonstrates that the
elongated α3 and α4 helices of SPS-1 block the binding of
Figure 8. Electron density maps for the S. smaragdinae SPS-1 active
site. (a and b) Two views of the SPS-1 active site with the 2Fo − Fc
map drawn at 1.5σ. (c and d) The same views of SPS-1 are shown
with an Fo − Fc omit map generated by Polder drawn at ±4σ with
positive density colored green and negative density colored red.
Throughout, key residues are shown as sticks and water molecules
(red) and zinc ions (gray) are shown as small spheres.
Figure 9. Overlay of S. smaragdinae SPS-1 and SPM-1 onto NDM-1
complexes with hydrolyzed antibiotics. The structures of SPS-1
(green, PDB entry 6CQS) and SPM-1 (light blue, PDB entry 4BP0)
were superimposed onto NDM-1 (pink, PDB entry 3Q6X) with SPS-
1 Zn(II) ions (gray), SPM-1 Zn(II) ions (navy blue), and NDM-1
Zn(II) ions (purple) shown as spheres. The square in panel a shows
the region used for insets b−e. Hydrolyzed antibiotics determined in
complex with NDM-1 are shown as sticks, including imipenem (cyan,
PDB entry 5YPL), meropenem (magenta, PDB entry 5YPK),
ampicillin (black, PDB entry 3Q6X), cephalexin (gray, PDB entry
4RL2), and cefuroxime (white, PDB entry 4RL0). The side chains of
SPS-1 residues Thr146 and Trp48 (yellow spheres) clash with
ampicillin, cephalexin, and cefuroxime.
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substrates that contain large substituents at the 6/7 position in
the β-lactam (Figure 9). Speciﬁcally, the phenyl substituents of
ampicillin and cephalexin clash with both Thr146 and Trp148,
while the furyl substituent of cefuroxime clashes with Thr146.
While it is not surprising that the potential steric clashes
(Figure 9b) correleate with the observed absence of activity by
SPS-1 against position 6/7-modiﬁed penems and cephems, the
structures of SPS-1 overlaid with ampicillin, cephalexin, and
cefuroxime also identify steric clashes; however, Murphy et al.
found that SPM-1 exhibits activity against ampicillin and
cefuroxime (cephalexin was not tested).12 The most likely
explanation for the disagreement for the SPM-1 structural and
activity data is that the SPM-1 structure was determined in the
absence of a substrate and the conformation of the SPM-1
Phe151 side chain is a favored rotamer, t80°, allowed in the
absence of any bound substrate. Interestingly, while electron
density for the backbone of helix α3 is well-resolved for SPM-
1, poor electron density for the Phe151 side chain is observed
within the electron density map of 4BP0 (Figure S4). Thus,
while the t80° Phe151 rotamer45 modeled into the original
SPM-1 crystal structure clashes with ampicillin, cephalexin, and
cefuroxime (Figure 9d), altering Phe151 to adopt a diﬀerent
favored rotamer,45 m−30°, resolves the predicted steric clash
and would allow SPM-1 to bind ampicillin, cephalexin, and
cefuroxime without altering the conformation of the SPM-1
backbone (Figure S4). In contrast, the backbone of SPS-1 helix
α3 positions Thr146 such that all possible Thr146 side chain
rotamers exhibit predicted steric clashes with ampicillin,
cephalexin, and cefuroxime (Figure 9b), consistent with the
observed SPS-1 substrate selectivity. Compared to the overlays
with cephems and penems, overlays of SPS-1 onto structures of
NDM-1 in complex with the carbapenems, imipenem46 and
meropenem29 (Figure 9), which lack a large substituent at the
6/7 position, do not predict any steric clashes between the
carbapenems and SPS-1. This is consistent with the observed
activity of SPS-1 against imipenem and meropenem.
It is clear that the diﬀerences in the relative position of
Zn(II) at the Zn1 site do not in general lead to a total loss of
hydrolytic activity as SPS-1 is active against antibiotics, such as
meropenem, which lack the phenyl or furyl substituents found
in ampicillin, cephalexin, and cefuroxime (Figure 9). Although
the 1 Å displacement of Zn(II) in the Zn1 site may also
contribute to steric clash by forcing the substrate upward, this
movement would only exacerbate the clashes predicted for
ampicillin, cephalexin, and cefuroxime. In contrast, this 1 Å
displacement of the Zn1 site would not preclude binding of
imipenem or meropenem. However, the diﬀerent position and
ligand environment of the Zn1 metal ion may explain the
relatively larger Km values exhibited by SPS-1, as compared to
those exhibited by NDM-1 and SPM-1 (Table 1). SPS-1 has
two water molecules that form a hydrogen bond network,
which accommodates the loss of a third coordinating histidine
found in the Zn1 sites of all other B1 MβLs (Figure 7). For the
dinuclear Zn(II)-containing MβLs, substrates are thought to
bind with the β-lactam carbonyl oxygen interacting with Zn1
and the carboxylate group of the β-lactam interacting with
Zn2.
1 Therefore, the diﬀerent active site geometry in SPS-1
may be the cause of the higher Km values observed for SPS-1
against all tested substrates, reﬂecting weaker substrate binding
to a ﬁrst approximation. Altered active site geometry leading to
weaker binding is also suggested by ITC studies with
competitive inhibitor captopril, which show that SPS-1 does
not bind captopril. These results suggest that the diﬀerent
position of the Zn1 metal leads to the inability of captopril to
bridge the Zn(II) ions in SPS-1. A surprising observation in the
steady-state kinetic studies was that despite a diﬀerent active
site structure, higher kcat values were exhibited by SPS-1
toward carbapenems. Given the phylogenetic grouping of SPS-
1 near the B2 MβLs, the positioning of the Zn1 metal above its
position in other B1 MβLs, and the observed steady-state
kinetic results, it is interesting to speculate that SPS-1 could be
an intermediate enzyme between the dinuclear Zn(II)-
containing MβLs (B1’s) and the mononuclear Zn(II)-
containing MβLs (B2’s).
We have previously reported spectroscopic studies of several
Co(II)-substituted MβLs, including NDM-1,27 VIM-2,4 IMP-
1,31 L1,36 BcI,47 CcrA,30 Bla2,48 and ImiS.22 In addition to
better understanding the active sites of these enzymes, these
studies have allowed us to probe the binding of metal to the
MβLs. Like most reported MβLs, the Co(II)-substituted
analogue of SPS-1 can be prepared by a direct method in
which native Zn(II) is removed with a chelator and dialysis
and the Co(II) analogue is prepared by adding Co(II) directly
to the metal-free enzyme.4,27 The UV−vis spectra of Co(II)-
substituted SPS-1 reveal an intense peak at 346 nm, which can
be attributed to a cysteine sulfur ligand-to-metal charge
transfer band. The intensity of that peak is greatest when
SPS-1 has 1 equiv of Co(II), demonstrating, as predicted from
the crystal structure, that the ﬁrst equivalent of metal binds to
the Zn2 site. The longer wavelength portion of the SPS-1
spectra is diﬀerent from those of most MβLs, which are often
dominated by intense ligand ﬁeld transitions between 450 and
600 nm from four-coordinate Co(II) in the Zn1 site (see the
control spectra of NDM-1 in Figure 3). Instead, the spectra of
Co(II)-substituted SPS-1 show a broad transition in this part
of the spectra, which can also be attributed to ligand ﬁeld
transitions. Similar spectra were reported for MβL L1. The
intensity (ε525 = 56 M
−1 cm−1) of the ligand ﬁeld transition(s)
in Co(II)-substituted SPS-1 suggests that Co(II) in the Zn2
site is ﬁve- or six-coordinate. The small increase in the intensity
of this peak upon addition of a second equivalent of Co(II),
which populates the Zn1 site, suggests that the coordination
number of Co(II) in the Zn1 site is six.
1H NMR and EPR spectra of Co(II)-substituted SPS-1
nicely correlate with the crystal structure of the Zn(II)-
containing enzyme. Three solvent-exchangeable peaks can be
assigned to histidine residues bound to high-spin Co(II), and
other resonances, by comparison to spectra of Co(II)-
containing MβLs, can be assigned to cysteine and aspartate
residues. The broader peaks observed in the NMR spectra of
Co(II)-substituted SPS-1, as compared to those in the spectra
of Co(II)-substituted NDM-1, suggest a slower T1e for the
unpaired electrons on Co(II) and Co(II) ions that are at best
weakly spin-coupled.49,50 The lack of spin coupling is clearly
observed in the parallel mode EPR spectra of Co(II)-
substituted SPS-1. The positioning of the metal ion in the
Zn1 site is most likely the cause of the loss of coupling and
nicely explains the lack of binding by captopril.
An intriguing question regarding SPS-1 is why S.
smaragdinae, speciﬁcally strain SEBR 4228T from a water
sample near a Congo oﬀshore oilﬁeld, produces an MβL.
Spirochetes are spiral-shaped bacteria and are pathogenic,
causing yaws, Lyme disease, relapsing fever, and syphilis.51 One
common treatment for some spirochete infections is the
administration of β-lactams,52 and it is possible that another
spirochete strain transferred resistance to S. smaragdinae strain
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SEBR 4228T. SPS-1 from S. smaragdinae has not been
identiﬁed in any patients, and there are no reports of any
human infections caused by S. smaragdinae. According to
Hatosy,53 there are four possible mechanisms to explain how
bacteria in the ocean gain antibiotic resistance. The ﬁrst
prediction is that antibiotic-resistant bacteria migrate from land
into marine environments. The second prediction is that
antibiotics enter into the marine environment, causing bacteria
to evolve antibiotic-resistant phenotypes. However, both of
these mechanisms seem unlikely because of the dilution of the
bacteria and antibiotics by the ocean. The third prediction is
that antimicrobial compounds are being produced in situ by
marine organisms, potentially to give these organisms a survival
advantage. The fourth prediction is that the proteins conferring
antibiotic resistance phenotypes mutated from a protein that
has a diﬀerent function in vivo. SPS-1, like other MβLs, adopts
a characteristic αββα fold. This αββα fold is found in a larger
superfamily of metalloenzymes, such as glyoxalase II,
arylsulfatase, and RNA-processing enzymes,54,55 with diverse
biological functions. It is important to note that the evolution
of one of these enzymes into a MβL would likely require the
presence of β-lactams to drive evolution.
■ CONCLUSIONS
Despite the question of why this spirochete produces a MβL,
SPS-1 is a unique MβL with a novel metal binding site. SPS-1
exhibits substrate speciﬁcity similar to that of the B2 MβLs, yet
SPS-1 can hydrolyze β-lactams other than carbapenems. The
novel ligand set for the SPS-1 active site provides a glimpse at
possible mutations in B1 MβLs that can still allow for β-lactam
hydrolysis, suggesting that broader diversity is possible for this
family of enzymes. The uncoupling of the Zn1 and Zn2 metal
sites identiﬁes SPS-1 as a possible intermediate between the
dinuclear Zn(II)-containing B1 MβLs and mononuclear
Zn(II)-containing B2-MβLs. Additional studies are needed to
better understand how the diﬀerent metal center in SPS-1
might aﬀect the mechanism of β-lactam hydrolysis and the
interaction with current and future inhibitor scaﬀolds.
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